Clinical trial
Etanercept in Hidradenitis Suppurativa
NCT00329823 · University of Athens, Other · Completed
Key facts
| NCT number | NCT00329823 |
|---|---|
| Title | Etanercept in Hidradenitis Suppurativa |
| Official title | A Phase 2 Study of the Safety and Efficacy of Etanercept for the Therapy of Hydradenitis Suppurativa |
| Lead sponsor | University of Athens, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hidradenitis Suppurativa |
| Intervention type | Drug |
| Interventions | Etanercept sc 50mg per week for 12 weeks |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Completion | May 1, 2006 |
| First posted | May 25, 2006 |
| Last update posted | May 25, 2006 |
| Countries | Greece |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: